GLP-1s were a primary driver. At companies with 5,000 or more workers, 43 percent covered GLP-1s for weight loss in 2025. Of ...

About 1 in 5 American adults have taken a GLP-1 medication, and most of them, including those with health insurance, say the ...

Use of liraglutide or semaglutide linked to improved remission rates ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. "From a public health ...

Managing GLP-1 side effects like nausea and constipation? Learn the supplements, including protein, HMB, probiotics and key vitamins, to maximize weight loss, preserve muscle mass and address common ...

A new research report reveals GLP-1 adoption isn't static, men are an overlooked demographic and usage varies dramatically by ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Between 11% and 12% of Americans took GLP-1s in 2026, a Gallup Poll found.